Mettler-Toledo International (NYSE:MTD) had its price target reduced by UBS Group from $680.00 to $670.00 in a research report sent to investors on Friday morning, AnalystRatings.com reports. UBS Group currently has a sell rating on the medical instruments supplier’s stock.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.
Other analysts also recently issued reports about the company. Barclays decreased their price target on Mettler-Toledo International from $680.00 to $640.00 and set an underweight rating on the stock in a research note on Wednesday, October 9th. Zacks Investment Research downgraded Mettler-Toledo International from a hold rating to a sell rating and set a $760.00 price target on the stock. in a research note on Tuesday, November 5th. Bank of America decreased their price target on Mettler-Toledo International from $830.00 to $720.00 and set a neutral rating on the stock in a research note on Thursday, October 17th. Finally, ValuEngine downgraded Mettler-Toledo International from a hold rating to a sell rating in a research note on Wednesday, October 2nd. Five analysts have rated the stock with a sell rating and one has assigned a hold rating to the company. The stock currently has an average rating of Sell and a consensus target price of $697.50.
Shares of Mettler-Toledo International stock traded down $11.95 during trading on Friday, reaching $708.86. The company’s stock had a trading volume of 410,664 shares, compared to its average volume of 167,265. The company has a quick ratio of 0.98, a current ratio of 1.39 and a debt-to-equity ratio of 2.16. Mettler-Toledo International has a 12-month low of $500.74 and a 12-month high of $873.51. The company has a market capitalization of $17.58 billion, a P/E ratio of 34.88, a price-to-earnings-growth ratio of 2.33 and a beta of 1.37. The business has a 50 day moving average price of $694.04 and a 200-day moving average price of $734.92.
Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $5.77 earnings per share for the quarter, beating the Zacks’ consensus estimate of $5.71 by $0.06. Mettler-Toledo International had a return on equity of 98.65% and a net margin of 18.45%. The firm had revenue of $753.90 million for the quarter, compared to the consensus estimate of $751.34 million. During the same period in the previous year, the business earned $5.12 earnings per share. The company’s revenue for the quarter was up 2.6% compared to the same quarter last year. Research analysts predict that Mettler-Toledo International will post 22.7 EPS for the current fiscal year.
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. boosted its position in Mettler-Toledo International by 1.2% during the second quarter. Vanguard Group Inc. now owns 2,773,530 shares of the medical instruments supplier’s stock worth $2,329,765,000 after purchasing an additional 34,044 shares in the last quarter. BlackRock Inc. boosted its position in Mettler-Toledo International by 7.4% during the second quarter. BlackRock Inc. now owns 1,858,924 shares of the medical instruments supplier’s stock worth $1,561,497,000 after purchasing an additional 128,157 shares in the last quarter. WCM Investment Management LLC boosted its position in Mettler-Toledo International by 3.5% during the second quarter. WCM Investment Management LLC now owns 1,548,699 shares of the medical instruments supplier’s stock worth $1,300,908,000 after purchasing an additional 52,874 shares in the last quarter. Bank of New York Mellon Corp boosted its position in Mettler-Toledo International by 1.8% during the second quarter. Bank of New York Mellon Corp now owns 365,142 shares of the medical instruments supplier’s stock worth $306,720,000 after purchasing an additional 6,332 shares in the last quarter. Finally, Northern Trust Corp boosted its position in Mettler-Toledo International by 3.0% during the second quarter. Northern Trust Corp now owns 350,784 shares of the medical instruments supplier’s stock worth $294,658,000 after purchasing an additional 10,145 shares in the last quarter. Institutional investors own 97.18% of the company’s stock.
About Mettler-Toledo International
Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; metal detection and other end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries; and solutions that are used in various process analytics applications.
See Also: Catch-Up Contributions